Anika TherapeuticsANIK
那斯達克 · USD
21.28
+0.02
(+0.09%)
盤中 08/21 12:10 (UTC+8)
08/21 12:10 (UTC+8)
Anika TherapeuticsANIK
21.28
+0.02
(+0.09%)
財務數據
損益表
- 0.29
- 0.53
- 0.39
- 0.31
- 0.26
- 0.28
- 0.28
- 0.31
- 0.30
- 0.33
- -32.46
- 84.07
- -27.46
- -21.03
- -
- 7.84
- -1.42
- 10.06
- -3.28
- 10.12
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 32,610 | 29,612 | 30,615 | 27,817 | 28,219 | 26,168 | 30,602 | 38,753 | 53,422 | 29,022 |
營業成本 | 11,366 | 10,615 | 11,436 | 12,233 | 13,856 | 11,487 | 13,476 | 37,313 | 20,404 | 10,047 |
營業毛利 | 21,244 | 18,997 | 19,179 | 15,584 | 14,363 | 14,681 | 17,126 | 1,440 | 33,018 | 18,975 |
營業費用 | 18,290 | 24,485 | 18,533 | 18,817 | 18,543 | - | 17,831 | 29,457 | 35,415 | - |
研發費用 | 7,341 | 6,713 | 6,452 | 6,946 | 6,313 | 6,059 | 6,507 | 7,244 | 9,153 | 6,409 |
推銷及管理費用 | 10,949 | 17,772 | 12,081 | 11,871 | 12,230 | 12,906 | 11,324 | 19,112 | 26,262 | 15,071 |
非經常性項目費用 | - | - | - | - | - | - | - | 3,101 | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 2,954 | -5,488 | 646 | -3,233 | -4,180 | -4,284 | -705 | -28,017 | -2,397 | -2,505 |
其他收入及費用 | 426 | 667 | 118 | 997 | 214 | - | - | 406 | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 3,380 | -4,821 | 764 | -2,236 | -3,966 | -3,869 | 39 | -27,611 | -1,802 | -1,913 |
所得稅 | 71 | 235 | -1,037 | 939 | 681 | 89 | 2,525 | 2,307 | 844 | 43 |
稅後純益 | 3,309 | -5,056 | 292 | -2,329 | -3,970 | -4,873 | -21,865 | -29,918 | -88 | -4,514 |
基本每股稅後盈餘(元) | 0.25 | -0.37 | 0.02 | -0.16 | -0.28 | -0.34 | -1.50 | -2.03 | -0.01 | -0.31 |
稀釋每股稅後盈餘(元) | 0.24 | -0.37 | 0.02 | -0.16 | -0.28 | -0.34 | -1.49 | -2.03 | - | -0.31 |
基本平均股數(千股) | 13330.00 | 13531.00 | 14273.00 | 14419.00 | 14364.00 | 14297.00 | 14576.00 | 14768.00 | 14839.00 | 14698.00 |
稀釋平均股數(千股) | 13717.00 | 13531.00 | 14669.00 | 14419.00 | 14517.00 | 14297.00 | 14576.00 | 14768.00 | 14839.00 | 14698.00 |
還原基本每股稅後盈餘(元) | 0.25 | -0.37 | 0.02 | -0.16 | -0.28 | -0.34 | -1.50 | -2.03 | -0.01 | -0.31 |
還原稀釋每股稅後盈餘(元) | 0.24 | -0.37 | 0.02 | -0.16 | -0.28 | -0.34 | -1.49 | -2.03 | - | -0.31 |
還原基本平均股數(千股) | 13,330 | 13,531 | 14,273 | 14,419 | 14,364 | 14,297 | 14,576 | 14,768 | 14,839 | 14,698 |
還原稀釋平均股數(千股) | 13,717 | 13,531 | 14,669 | 14,419 | 14,517 | 14,297 | 14,576 | 14,768 | 14,839 | 14,698 |
EBITDA(千元) | 4,885 | -3,414 | 573 | 13 | -1,873 | -3,192 | -17,528 | -25,423 | 2,814 | -2,408 |